Junhui Xia Selected Research

TM 1

2/2022

Incidence and risk factors for venous thromboembolism during an acute attack in patients with neuromyelitis optica spectrum disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junhui Xia Research Topics

Disease

6	Neuromyelitis Optica (Devic's Disease) 01/2022 - 06/2017
2	Transverse Myelitis (Necrotizing Myelitis) 02/2022 - 12/2016
2	Optic Neuritis (Retrobulbar Neuritis) 01/2022 - 12/2016
1	Autoimmune Diseases (Autoimmune Disease) 10/2022
1	Sjogren's Syndrome (Sjogren Syndrome) 10/2022
1	Blindness (Hysterical Blindness) 01/2022
1	Myelitis 01/2022
1	Polyneuropathies (Polyneuropathy) 06/2018
1	Leukocytosis (Pleocytosis) 01/2017

Drug/Important Bio-Agent (IBA)

3	Rituximab (Mabthera)FDA Link 01/2022 - 01/2018
2	Azathioprine (Imuran)FDA LinkGeneric 01/2022 - 06/2017
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 01/2022
1	Iodide Peroxidase (Deiodinase)IBA 10/2022
1	AntibodiesIBA 10/2022
1	Antinuclear AntibodiesIBA 10/2022
1	TM 1IBA 02/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2021
1	GlucocorticoidsIBA 06/2018
1	Monoclonal AntibodiesIBA 08/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	CytokinesIBA 12/2016

Therapy/Procedure

3	Therapeutics 01/2022 - 08/2017